Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Complete title: AGCT1531, Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Research Study Number AGCT1531
Principal Investigator Abby Rosenberg
Phase III

Research Study Description

This partially randomized phase III trial studies how well active surveillance, bleomycin, carboplatin, etoposide, or cisplatin work in treating pediatric and adult patients with germ cell tumors. Active surveillance may help doctors to monitor subjects with low risk germ cell tumors after their tumor is removed. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "LOOK UP TRIAL AT NIH" link above. **

Other eligibility criteria may apply.

Research Study Number AGCT1531
Contact Abby Rosenberg
Telephone 206/667-3709

Keywords: Pediatric Cancers, Miscellaneous; Ovarian Cancer; Solid Tumors; Teratomas; Neoplasms, Germ Cell and Embryonal; Urogenital Neoplasms; Neoplasms, Glandular and Epithelial; Adenocarcinoma; Genital Neoplasms, Female; Carcinoma; Endocrine Gland Neoplasms; Adnexal Diseases; Trophoblastic Neoplasms; Gonadal Disorders; Carcinoma, Embryonal; Choriocarcinoma; Endodermal Sinus Tumor; Mesonephroma; Pregnancy Complications, Neoplastic; Pregnancy Complications

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials